top of page
Revolve Access Logo
Welcome to Revolve

Make confident business decisions in Federal

LEARN MORE

Military mom hugging child

Revolve helps emerging and established pharma, biopharma, and device companies effectively navigate Federal health systems.  

3-Part Series

How It Works

Federal Market Insights: VA & DoD Access

Developed in partnership with Life Science Leader.​

​Navigating VA and DoD market access can be complex, and we’re here to help ground you in the essentials. Our aim is to share foundational knowledge that supports bringing better therapies to this important segment more efficiently.

Read More
1_edited.jpg
lsl-800px-wide_edited.png
Read More
2_edited.jpg
lsl-800px-wide_edited.png
Read More
3_edited.jpg
lsl-800px-wide_edited.png

The Federal Healthcare Market Is About to Change - Are You Ready?

Structural shifts across VA and DoD in 2026 will redefine formulary access, contracting, and execution for manufacturers. Learn what’s coming, and what it means for your federal strategy.

Subscribe to get insights, expert perspectives, and emerging trends

Thanks for submitting!

2026Changes

CLIENTS

[CLASSIFIED]

BIOPHARMA

Large, Mid & Small-Cap Pharma

​

Specialty, Rare Disease, Cell/Gene

​

Biosimilars, Mature Brands

DEVICE

​

Medical Equipment & Med / Surg Supplies

 

Med Tech & Diagnostics 

 

Surgical Implants & Device

OTHER

Private Equity & VC

 

OTC, PPE & Supplements

 

Resellers & Dealers

​

​

How can we assist you?

The Federal healthcare landscape is vast, complex, and often misunderstood — yet it represents one of the most consequential segments in U.S. healthcare. As expectations evolve amid rapid market shifts, manufacturers must engage with increasing agility and strategic foresight. Our clients rely on our long-standing credibility within the VA and DoD to navigate this dynamic environment.

bottom of page